NCT04061044View on ClinicalTrials.gov

A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

February 10, 2020

Study Completion Date

September 22, 2020

Conditions
Open Angle Glaucoma and Ocular Hypertension
Interventions
DRUG

Ophthalmic Insert

Travoprost, 0.32 mg

Trial Locations (1)

45242

ApexEye, Cincinnati

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY

NCT04061044 - A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert | Biotech Hunter | Biotech Hunter